4.5 Article

Identification of a novel mutation in CYBB gene in a Chinese neonate with X-linked chronic granulomatous disease A case report

Related references

Note: Only part of the references are listed.
Article Cell Biology

CYBB/NOX2 in conventional DCs controls T cell encephalitogenicity during neuroinflammation

Christian W. Keller et al.

Summary: This study reveals that the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 2 in conventional dendritic cells (cDCs) regulates MOG antigen processing through LC3-associated phagocytosis (LAP), enabling encephalitogenic T helper cells to initiate and sustain autoimmune neuroinflammation. Genetic ablation of Cybb in cDCs restrains T-H cell recruitment into the CNS and ameliorates clinical disease development upon the adoptive transfer of MOG-specific CD4(+) T cells.

AUTOPHAGY (2021)

Review Allergy

Chronic Granulomatous Disease: a Comprehensive Review

Hsin-Hui Yu et al.

Summary: Chronic granulomatous disease (CGD) is a primary immunodeficiency caused by defective NADPH oxidase, presenting with various types and manifestations. Treatment options are diverse, including interventions to manage symptoms and hematopoietic stem cell transplantation.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2021)

Article Immunology

Primary Immunodeficiencies in India: Molecular Diagnosis and the Role of Next-Generation Sequencing

Arun Kumar Arunachalam et al.

Summary: This study characterized the clinical and genetic spectrum of PID patients in India, identifying BTK and IL12RB1 as the most common mutated genes, with autosomal recessive and X-linked recessive inheritance in 51.6% and 23.7% of patients, respectively. MSMD and IL12RB1 mutations were more common in this population compared to the Western world and the Middle East.

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

Article Pathology

Clinical Metagenomic Next-Generation Sequencing for Pathogen Detection

Wei Gu et al.

Annual Review of Pathology-Mechanisms of Disease (2018)

Review Biology

Chronic granulomatous disease: why an inflammatory disease?

P. Roxo-Junior et al.

BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2014)

Article Genetics & Heredity

Gene Therapy for Chronic Granulomatous Disease: Current Status and Future Perspectives

Kerstin B. Kaufmann et al.

CURRENT GENE THERAPY (2014)

Article Immunology

Targeted NGS: a cost-effective approach to molecular diagnosis of PIDs

Jennifer L. Stoddard et al.

FRONTIERS IN IMMUNOLOGY (2014)

Article Allergy

Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients

Mustafa Yavuz Koker et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)

Article Biochemistry & Molecular Biology

Oculocutaneous Albinism Type 3 (OCA3): Analysis of Two Novel Mutations in TYRP1 Gene in Two Chinese Patients

Kai-hui Zhang et al.

CELL BIOCHEMISTRY AND BIOPHYSICS (2011)

Review Biochemistry & Molecular Biology

The superoxide-generating NADPH oxidase: structural aspects and activation mechanism

PV Vignais

CELLULAR AND MOLECULAR LIFE SCIENCES (2002)

Article Immunology

CYBB mutation analysis in X-linked chronic granulomatous disease

O Jirapongsananuruk et al.

CLINICAL IMMUNOLOGY (2002)